|
Product Name |
Thymopentin |
|
CAS NO. |
69558-55-0 |
|
EINECS NO. |
/ |
|
Molecular formula |
C30H49N9O9 |
|
Molecular weight |
679.765 |
|
Density |
1.44g/cm3 |
Thymopentin is an immunostimulant. As such, it has been used in several clinical studies in the early years of the AIDS pandemic (from 1983 to 1985). Thymopentin helped to improve immunological condition in several patients for a brief time under specific treatments.
| Items | Standard |
|
Characteristics
Specific rotation |
White or off-white powder -14°~22° |
| Identification Biuret reaction IR HPLC |
Positive |
| Clarity | Clear |
| Alkalinity | 7.0~9.0 |
| Water | ≤5.0% |
| Amino acid composition | Conforms |
| Related substances | Single substance ≤1.5% Total substance ≤2.5% |
| Endotoxin | ≤5Eu/mg |
| Assay |
| 99.0%~101.0% |
Benefits:
Functions of Thymopentin
It can be used in patients with malignant tumors after chemoradiotherapy, immune function impairment; treatment of hepatitis B; major surgery and serious infection; autoimmune diseases such as rheumatoid arthritis, lupus erythematosus; type II diabetes, climacteric syndrome Older and younger people with lower immune function.
(1) For patients with chronic hepatitis B over 18 years of age.
(2) various primary or secondary T cell deficiency diseases (such as children with congenital immunodeficiency disease).
(3) Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus).
(4) Various diseases with low cellular immune function.
(5) Adjuvant therapy for tumors.
Related Products:
| Product Name | CAS No. |
| Thymopentin | 69558-55-0 |
| glutathione | 70-18-8 |
| Liraglutide injection | 204656-20-2 |
| Glycyl-L-Histidyl-L-Lysine | 49557-75-7 |
| biotinoyl Tripeptide-1 | 299157-54-3 |
| Acetyl Hexapeptide-8 | 616204-22-9 |
